These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4815179)

  • 1. Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin.
    Parker DC; Rossman LG; Siler TM; Rivier J; Yen SS; Guillemin R
    J Clin Endocrinol Metab; 1974 Mar; 38(3):496-9. PubMed ID: 4815179
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 4. Disappearance of plasma growth hormone in acromegaly and protein-calorie malnutrition after somatostatin.
    Pimstone BL; Becker D; Kronheim S
    J Clin Endocrinol Metab; 1975 Jan; 40(1):168-71. PubMed ID: 803512
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of growth hormone release in humans by somatostatin.
    Siler TM; VandenBerg G; Yen SS; Brazeau P; Vale W; Guillemin R
    J Clin Endocrinol Metab; 1973 Oct; 37(4):632-4. PubMed ID: 4742541
    [No Abstract]   [Full Text] [Related]  

  • 6. Abscence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly.
    Carlson HE; Gillin JC; Gorden P; Snyder F
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1102-5. PubMed ID: 5020420
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.
    Pieters GF; Romeijn JE; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 May; 54(5):942-8. PubMed ID: 6120951
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth hormone secretion in the rat by synthetic somatostatin.
    Brazeau P; Rivier J; Vale W; Guillemin R
    Endocrinology; 1974 Jan; 94(1):184-7. PubMed ID: 4808882
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Somatostatin (somatotrophin release inhibiting factor).
    S Afr Med J; 1974 Jun; 48(28):1180. PubMed ID: 4599981
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of single doses of indomethacin and aspirin on the serum growth hormone concentration in acromegaly].
    Pawlikowski M; Owczarczyk I
    Endokrynol Pol; 1981; 32(4):315-8. PubMed ID: 7308171
    [No Abstract]   [Full Text] [Related]  

  • 14. Unaltered plasma GH levels in acromegalics and normal men and women after administration of (Pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing hormone.
    Gonzalez-Barcena D; Kastin AJ; Coy DH; Glick S; Schalch DS; Lee LA; Arzac JP; Schally AV
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1134-6. PubMed ID: 4831709
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Somatostatin: newcomer from the hypothalamus.
    Brazeau P; Gullemin R
    N Engl J Med; 1974 Apr; 290(17):963-4. PubMed ID: 4206096
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of synthetic somatostatin in normal and acromegalic males].
    Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man.
    Schally AV; Coy DM; Kastin AJ; Tunbridge WM; Evered DC; Weightman D; Hall R; Besser GM; Goldie DJ; McNeilly AS; Mortimer CH; Phenekos C
    J Endocrinol; 1974 Apr; 61(1):XIV. PubMed ID: 4208301
    [No Abstract]   [Full Text] [Related]  

  • 19. Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
    Chihara K; Kato Y; Abe H; Furumoto M; Maeda K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):78-84. PubMed ID: 576232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor.
    Siler TM; Yen SC; Vale W; Guillemin R
    J Clin Endocrinol Metab; 1974 May; 38(5):742-5. PubMed ID: 4207367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.